Acetylcholine stimulated dilatation and stretch induced myogenic constriction in mesenteric artery of rats with chronic heart failure

European Journal of Heart Failure

Volumn 9, Issue 2, 2007, Pages 144-151

  Xu, Y ^a   Henning, R H ^a   Lipsic, E ^a   van Buiten, A ^a   van Gilst, W H ^a   Buikema, H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Chronic heart failure; EDHF; Mesenteric artery; Myocardial infarction; Myogenic constriction; NO

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY LIGATION; CORRELATION ANALYSIS; HEART FAILURE; HEART FUNCTION; MALE; MESENTERIC ARTERY; MORPHOMETRICS; MUSCLE STRETCHING; MYOGRAPHY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; STATISTICAL SIGNIFICANCE;

ACETYLCHOLINE; ANIMALS; BIOLOGICAL FACTORS; ENDOTHELIUM; HEART FAILURE, CONGESTIVE; MALE; MESENTERIC ARTERIES; MODELS, ANIMAL; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33847791841     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.05.003     Document Type: Article

References (33)

1. Zelis R., and Flaim S.F. Alternations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 14 (1982) 437-459
2. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
3. Ledoux J., Gee D.M., and Leblanc N. Increased peripheral resistance in heart failure: new evidence suggests an alteration in vascular smooth muscle function. Br J Pharmacol 139 (2003) 1245-1248
4. Bauersachs J., Bouloumie A., Fraccarolo D., Hu K., Busse R., and Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanlylate cyclase expression. Role of enhanced superoxide production. Circulation 100 (1999) 292-298
5. Monnink H., Buikema S.H.J., Tio R.A., Crijns H.J.G.M., de Zeeuw D., and van Gilst W.H. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure. Br J Pharmacol 130 (2000) 1999-2007
6. Indik J., Goldman S., and Gaballa M. Oxidative stress contributes to vascular endothelial dysfunction in heart failure. Am J Physiol Heart Circ Physiol 281 (2001) H1767-H1770
7. Schafer A., Fraccarollo D., Tas P., Schmidt I., Ertl G., and Bauersachs J. Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism. Eur J Heart Fail 6 (2004) 151-159
8. Shimokawa K., Yasutake H., Fuji K., et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28 (1996) 703-711
9. Buus N.H., Kahr O., and Mulvany M.J. Effect of short- and long-term heart failure on small artery morphology and endothelial function in the rat. J Cardiovasc Pharmacol 34 (1999) 34-40
10. Brandes R.P., Walles T., Koddenberg G., Gwinner W., and Mügge A. Endothelium-dependent vasodilatation in Spraque-Dawley rats with postinfarction hypertrophy: lack of endothelial dysfunction in vitro. Basic Res Cardiol 93 (1998) 463-469
11. Malmsjö M., Bergdahl A., Zhao X.-H., et al. Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res 43 (1999) 200-209
12. Thuillez C., Mulder P., Elfertak L., et al. Prevention of endothelial dysfunction is small and large arteries in a model of chronic heart failure. Effect of angiotensin converting enzyme inhibition. Am J Hypertens 8 (1995) 7S-12S
13. Bergdahl A., Valdemarsson S., Nilsson T., Sun X.Y., Hedner T., and Edvinsson L. Dilatory responses to acetylcholine, calcitonin gene-related peptide and substance P in the congestive heart failure rat. Acta Physiol Scand 165 1 (1999) 15-23
14. Davis M.J., and Hill M.A. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79 (1999) 387-423
15. 1 receptor blockade. Br J Pharmacol 139 (2003) 1317-1325
16. Ca channels. Hypertension 41 (2003) 912-918
17. Delaey C., Boussery K., and van de Voorde J. Contractility studies on isolated bovine choroidal small arteries: determination of the active and passive wall tension-internal circumference relation. Exp Eye Res 75 (2002) 243-248
18. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., et al. Myocardial infarct size and ventricular function in rats. Circ Res 44 (1979) 503-512
19. Van Gilst W.H., van Veldhuisen D.J., Hegeman H., et al. Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril. J Cardiovasc Pharmacol 24 (1994) 171-174
20. Peiper U., Schmidt E., Laven R., and Griebel L. Length-tension relationships in resting and activated vascular smooth muscle fibres. Pflugers Arch 340 (1973) 113-122
21. Õzkan M.H., and Uma S. Inhibition of acetylcholine-induced EDHF response by elevated glucose in rat mesenteric artery. Life Sci 78 (2005) 14-21
22. Kubo S.H., Rector T.S., Bank A.J., Williams R.E., and Heifetz S.M. Endothelium-dependent vasodilatation is attenuated in patients with heart failure. Circulation 84 (1991) 1589-1596
23. Wang J., Sevanian A., Xu X.B., Wollin M.S., and Hintze T.H. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol 266 (1994) H670-H680
24. Ramsey M.W., Goodfellow J., Jones C.J.H., Luddington L.A., Lewis M.J., and Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 92 (1994) 3212-3219
25. Christensen K.L., and Mulvany M.J. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res 30 (1993) 73-79
26. Bauersachs J., Popp R., Hecker M., Sauer E., Flemming I., and Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94 (1996) 3341-3347
27. Feletou M., and Vanhoutte P.M. Endothelial dysfunction: a novel therapeutic target; The alternative: EDHF. J Mol Cell Cardiol 31 (1999) 15-22
28. Näbauer M., and Kääb S. Potassium channel down-regulation in heart failure. Cardiovasc Res 37 (1998) 324-334
29. Toro L., Marijic J., Nishimura K., Tanaka Y., Song M., and Stefani E. Aging, ion channel expression, and vascular function. Vascul Pharmacol 38 1 (2002) 73-80
30. Gutterman D.D., Miura H., and Liu Y. Redox modulation of vascular tone. Focus of potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol 25 (2005) 671-678
31. Fleming I. Cytochrome p450 and vascular homeostasis. Circ Res 89 9 (2001) 753-762
32. Harder D.R., Lange A.R., Gebremedhin D., Birks E.K., and Roman R.J. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res 34 3 (1997) 237-243
33. Minamiyama Y., Takemura S., Imaoka S., Funae Y., Tanimoto Y., and Inoue M. Irreversible inhibition of cytochrome P450 by nitric oxide. J Pharmacol Exp Ther 283 3 (1997) 1479-1485